Skip to main content

Medical Marijuana Market Size [2022-2028] | to Reach USD 26,920.4 Million, at a Stellar 20.04% CAGR

Written by Customer Service on . Posted in Mergers And Acquisitions.

Medical Marijuana Markets to Reach USD 26,920.4 Million by 2026: Rise in Research Activities for Medicinal Properties of Cannabis to Bode Well for Market, Reports Fortune Business Insights™

Pune, India, Feb. 10, 2022 (GLOBE NEWSWIRE) — The Medical Marijuana Market Size to Rise at a Stellar 20.04% CAGR, and Hit USD 26,920.4 Million by 2026. Rising Demand for Legalization of Marijuana in Most States will Promote Growth, says Fortune Business Insights™. A recently published report by Fortune Business Insights™ titled, “Market Size, Share & Industry Analysis, By Application (Pain Disorders, Cancer, and Others), By Type (Flowers, Concentrates, Edibles and Others), By Distribution Channel (Dispensaries, Online, and Others), and Regional Forecast, 2019-2026” discusses the market comprehensively.

Market Growth Reasons:

  • Increasing Awareness about Benefits of Medical Marijuana to Boost the Market
  • Increasing preference towards inhalation route of administration leads to higher demand
  • Increasing Authorization of Marijuana to Offer Significant Opportunity for Market Expansion
  • FDA Approval of Marijuana for Treating Epilepsy Driving Market Expansion


Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-marijuana-market-102609


Market Growth Factors:

  • The increasing demand for legalization of medical cannabis across various states is a major medical marijuana market growth driver. Besides this, the rising prevalence of diseases such as Parkinson’s disease, cancer, neurological disorders, and acute pain diseases is also expected to aid in expansion of the market in the forecast period.
  • Medical marijuana has various applications in the healthcare field, such as treating or managing epilepsy and other neurological disorders. In June 2018, FDA gave approval to the first drug consisting of an active ingredient derived from marijuana for treating epilepsy.
  • The inhalation route of administration dominated more than 72.4% of the medical marijuana market share in 2020. One of the prominent reasons for this significant dominance is the reduced latency of actions relative to other routes of administration.


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/medical-marijuana-market-102609


Market Segmentations:

Based on application – The global market for medical marijuana is segmented into cancer, schizophrenia, Alzheimer’s disease, and multiple sclerosis.

By type segment – The market is classified as flowers, edibles, concentrates, and others. The flowers segment is anticipated to hold a considerable market share across the forecast period.

In terms of distribution channel – The market is segmented into dispensaries, online portals and others. The dispensaries segment held substantial market share in the year 2018 and is estimated to witness favorable growth across the forecast period.


Quick Buy – Medical Marijuana Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102609


Regional Analysis:

Increasing Awareness on medicinal Properties of Cannabis to Offer Lucrative Growth Opportunities for the Rest of the World

  • Geographically, North America earned the maximum medical marijuana market share with a revenue of USD 5,994.9 million earned in 2018, that is anticipated to reach USD 24,578.3 million by the end of 2026.
  • Growth of this region is attributed to the rise in the number of legalization of marijuana for both medical and recreational purposes, coupled with the presence of major vendors in the region.
  • Europe ranks second in terms of cannabis cultivation and is expected to witness significant growth owing to the increasing investments for research activities by many public and private entities in the forthcoming years.


Competitive Landscape:

Entry of New Players will Intensify Market Competition

The rapid developmental pace of medical marijuana and its wide expansion has propelled many players to enter into this market and make heavy investments in research and development of the same. Although the most crucial part is its production and cultivation, significant medical marijuana market revenue is derived from the pharmacological organizations.


Ask for Customization of this Report:  https://www.fortunebusinessinsights.com/enquiry/customization/medical-marijuana-market-102609


Key Medical Marijuana Markets Manufacturers are:

•             Aurora Cannabis

•             CannTrust Holdings

•             MedReleaf Corp

•             Emerald Health Therapeutics

•             The Cronos Group

•             Green Relief Inc.

•             Medical Marijuana, Inc.

•             ABcann Medicinals, Inc.

•             GW Pharmaceuticals

•             Aphria Inc.

•             Canopy Growth Corporation

•             Other Vendors


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.